AI-Powered Workflow for Ingestion and Normalization of Spontaneous Report Data

This workflow directly attacks the most labor-intensive bottleneck in pharmacovigilance: manual data entry from unstructured sources. By deploying LLM agents to extract patient demographics, drug details, and event narratives into standardized ICSR fields, teams eliminate repetitive transcription, reduce human error, and accelerate case processing. The operational upside comes from reallocating FTEs from data typing to higher-value medical review and signal analysis, while improving data quality for downstream reporting and analytics. Implementation requires integrating with existing intake channels like ServiceNow or custom web forms.

Architecturally, the solution is a pipeline of specialized agents orchestrated by LangGraph for state management. The LLM extraction agent uses retrieval-augmented generation (RAG) over product monographs and MedDRA to improve accuracy. Critical controls include configurable validation rules, a human-in-the-loop correction queue in Veeva Safety for low-confidence extractions, and full audit trails for compliance. Integration points are the intake channels, the legacy safety database (e.g., Oracle Argus), and the quality management system for logging processing exceptions.

This workflow automates the high-volume, repetitive bottleneck of manually keying data from faxes, emails, and web forms into pharmacovigilance systems. The operational upside comes from slashing per-case processing time from hours to minutes, improving data quality through structured validation, and freeing safety associates for higher-value medical review. Implementation requires a stateful orchestrator, such as LangGraph, to manage document parsing, multi-agent extraction, and human-in-the-loop correction queues while integrating with legacy APIs.

The architecture is built for enterprise constraints, including data quality gates, MedDRA terminology validation, and audit trails for compliance. Each agent handles a discrete task—document classification, entity extraction, or field mapping—with the orchestrator managing retries and exception routing. Rollout requires phased integration with existing intake channels and safety databases, alongside configurable approval thresholds to control the automation's confidence level before escalating to human reviewers.

Phase 1 establishes the core document processing pipeline, targeting the highest-volume unstructured sources like web forms and PDF emails. An orchestration layer, built with LangGraph, triggers LLM agents to extract patient demographics, drug details, and event narratives into ICSR fields. This initial phase delivers the foundational 70% reduction in manual data entry, with all outputs routed to a human-in-the-loop correction queue in a staging database before any integration with production systems like Oracle Argus or Veeva Safety.

Phase 2 integrates the validated, normalized output into the production safety database, establishing automated E2B-ready data flows. This phase introduces configurable approval gates and observability dashboards to monitor throughput, exception rates, and data quality drift. The final phase expands source coverage to complex formats like handwritten faxes and call center transcripts, leveraging the now-trusted pipeline. This staged approach ensures each increment delivers measurable labor savings while preserving auditability and medical oversight.

This workflow automates the high-volume, repetitive bottleneck of manual data entry from unstructured spontaneous reports. The operational upside comes from compressing case processing timelines from days to hours, reducing labor costs, and improving data quality for downstream signal detection. Implementation requires a multi-stage pipeline: ingestion agents pull from source APIs and email servers, an LLM orchestration layer extracts and normalizes entities to MedDRA and WHO-DD standards, and validation rules are applied before data is queued for human review. The architecture must integrate with legacy safety databases like Oracle Argus or Veeva Safety, requiring robust API design and state management, typically using a framework like LangGraph.

Governance is non-negotiable. The workflow must include configurable approval gates for low-confidence extractions, full audit trails for all data transformations, and integration with quality management systems for deviation tracking. Rollout requires a phased approach: begin with a single report source and a closed-loop human-in-the-loop review process, then expand as confidence scores improve. Monitoring must track extraction accuracy, throughput, and exception rates, with alerts for pipeline failures. This creates a scalable, compliant architecture that turns a costly manual process into a controlled, high-throughput automation layer.

This workflow automates the high-volume, repetitive bottleneck of manually transcribing and coding unstructured adverse event reports. The operational upside comes from slashing data-entry labor, reducing processing time from hours to minutes per case, and drastically improving data quality for downstream analysis and regulatory reporting. Savings are direct in FTE reduction and indirect in lowered risk of reporting delays or errors. Implementation requires orchestrating document ingestion, LLM-based field extraction against MedDRA and WHO-DD, validation against business rules, and seamless integration with safety databases like Oracle Argus or Veeva Safety.

Implementation centers on a state-managed orchestrator, such as LangGraph, coordinating specialized agents for OCR, entity extraction, and terminology coding. Critical controls include configurable validation rules, a human-in-the-loop queue for low-confidence extractions, and immutable audit logging of every transformation for inspection. The architecture must handle exception routing for ambiguous data, support phased rollout by report source, and integrate with existing quality management systems to trigger investigations for systematic extraction failures, ensuring the workflow enhances rather than compromises regulatory posture.